rts logo

New Big Money Means Procept BioRobotics Corp (PRCT) Investors Could Reap Benefit

Procept BioRobotics Corp (NASDAQ: PRCT) is -30.41% lower on its value in year-to-date trading and has touched a low of $45.56 and a high of $103.81 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRCT stock was last observed hovering at around $57.59 in the last trading session, with the day’s loss setting it -1.56%.

Currently trading at $56.03, the stock is -11.32% and -20.97% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing -2.71% at the moment leaves the stock -24.94% off its SMA200. PRCT registered 16.03% gain for a year compared to 6-month loss of -27.18%. The firm has a 50-day simple moving average (SMA 50) of $70.8973 and a 200-day simple moving average (SMA200) of $74.65012.

The stock witnessed a -15.11% gain in the last 1 month and extending the period to 3 months gives it a -39.44%, and is -7.51% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.50% over the week and 6.34% over the month.

Procept BioRobotics Corp (PRCT) has around 756 employees, a market worth around $3.07B and $224.50M in sales. Profit margin for the company is -40.72%. Distance from 52-week low is 22.98% and -46.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.02%).

The EPS is expected to grow by 13.70% this year

389.0 institutions hold shares in Procept BioRobotics Corp (PRCT), with institutional investors hold 99.28% of the company’s shares. The shares outstanding are 54.72M, and float is at 51.84M with Short Float at 9.80%. Institutions hold 94.60% of the Float.

The top institutional shareholder in the company is FMR LLC with over 7.29 million shares valued at $445.33 million. The investor’s holdings represent 14.1215 of the PRCT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.71 million shares valued at $287.87 million to account for 9.2375 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.49 million shares representing 6.8328 and valued at over $212.93 million, while ALLIANCEBERNSTEIN L.P. holds 3.5046 of the shares totaling 1.81 million with a market value of $110.52 million.

Procept BioRobotics Corp (PRCT) Insider Activity

The most recent transaction is an insider sale by Nouri Alaleh, the company’s EVP, CLO, CORP. SEC. SEC filings show that Nouri Alaleh sold 3,641 shares of the company’s common stock on Mar 06 ’25 at a price of $61.31 per share for a total of $0.22 million. Following the sale, the insider now owns 61789.0 shares.

Procept BioRobotics Corp disclosed in a document filed with the SEC on Mar 06 ’25 that Shiblaq Hisham (EVP, Chief Comm. Officer) sold a total of 3,588 shares of the company’s common stock. The trade occurred on Mar 06 ’25 and was made at $61.31 per share for $0.22 million. Following the transaction, the insider now directly holds 63380.0 shares of the PRCT stock.

Still, SEC filings show that on Mar 06 ’25, Waters Kevin (EVP, CFO) disposed off 3,662 shares at an average price of $61.31 for $0.22 million. The insider now directly holds 108,724 shares of Procept BioRobotics Corp (PRCT).

Related Posts